In the vast majority of our long-term test stories, this is where we say goodbye. But since we own our Maverick—and we still ...

Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases Transaction further ...